Several widely used epilepsy drugs can lower birth control hormone levels enough to raise pregnancy risk, and U.S. guidance now says so plainly.
Story Snapshot
- U.S. clinical guidance warns certain seizure drugs can weaken combined hormonal contraception.
- The mechanism is enzyme induction in the liver that speeds hormone breakdown.
- Named drugs include carbamazepine, phenytoin, phenobarbital, primidone, oxcarbazepine, felbamate, and topiramate.
- A 2021 analysis tied these pairings to more unintended pregnancies with oral pills.
What the new guidance actually says
The Centers for Disease Control and Prevention updated its U.S. Medical Eligibility Criteria to flag a clear risk. Certain antiseizure medicines are likely to reduce the effectiveness of combined hormonal contraception, which includes the pill, patch, and ring. The document lists specific drugs. It does not treat all epilepsy medicines as the same. That precision matters, because many people rely on both therapies at the same time, and the wrong match can have real consequences.
The Centers for Disease Control and Prevention also explains why this happens. Some antiseizure drugs switch on liver enzymes, especially the cytochrome P450 3A pathway. That pathway breaks down ethinyl estradiol and several progestins. Faster breakdown lowers hormone levels in the blood and can let ovulation slip through. This is not a scare story. It is a straightforward drug–drug interaction, taught in pharmacology and backed by long clinical use.
Which medicines are the problem—and which are not
The risk centers on enzyme inducers. Carbamazepine, phenytoin, phenobarbital, primidone, oxcarbazepine, felbamate, and topiramate show this effect to varying degrees. These drugs speed hormone clearance and can push combined hormonal contraception below the level needed to prevent pregnancy. Other seizure medicines do not share this effect. Options like lamotrigine, levetiracetam, valproate, and gabapentin are not enzyme inducers. Lumping all epilepsy drugs together leads to bad counseling and bad outcomes.
This is also not only a one-way street. Estrogen-containing contraceptives can lower levels of some seizure drugs, most notably lamotrigine, by increasing its clearance. That can raise seizure risk if clinicians do not adjust dosing. Patients deserve counseling that covers both directions of the interaction, so they can plan safely with their doctors.
What the numbers say about pregnancy risk
Modeling work published in 2021 linked the pairing of enzyme-inducing seizure drugs with oral contraceptives to more unintended pregnancies than matched pairings with enzyme-neutral drugs. The authors estimated hundreds of extra unintended pregnancies per year in the United States among pill users on enzyme inducers. The estimate is not a randomized trial, but it aligns with the known mechanism and decades of bedside caution. That convergence supports common-sense steps to reduce risk.
Practical choices that reduce the risk today
The first line of defense is method selection. Intrauterine devices, both copper and levonorgestrel, do not rely on liver metabolism the same way and keep their effectiveness with enzyme inducers. The same is true for the depot medroxyprogesterone shot. Combined hormonal pills, patches, and rings face the greatest risk with these seizure drugs. Progestin-only pills and the etonogestrel implant can also be affected, depending on the specific drug and dose.
Study Examines How Epilepsy Drugs May Affect Birth Control – EPILESSIA NEL MONDO / EPILEPSY IN THE WORLD https://t.co/uxg7Lt0BvL pic.twitter.com/QBSizjIkhv
— EPILESSIA.INFO (@EPILESSIAINFO) October 12, 2026
When combined hormonal contraception is still preferred, add a barrier method, like condoms, during any course of enzyme-inducing therapy. Some professional guidance recommends this back-up approach when inducers cannot be avoided, which fits a better-safe-than-sorry mindset. For women taking topiramate at lower migraine doses, clinicians should still check the exact dose and consider a nonhormonal or long-acting reversible method if pregnancy would pose serious risk.
Clear talk at the pharmacy counter
Every new prescription for an enzyme-inducing seizure drug should trigger a fast, plain-language check on birth control. Pharmacists and clinicians can run a quick list review, confirm the contraceptive method, and offer two or three safe alternatives on the spot. Patients should not have to decode enzyme charts. They need simple options that fit their life: switch to an intrauterine device, choose the shot, or keep the pill and add condoms. That is practical, and it prevents regrets.
What to ask your doctor right now
Ask which seizure drug you take and whether it is an enzyme inducer. Ask whether your current birth control depends on those liver pathways. If yes to both, ask for a method that is not affected, like an intrauterine device or the shot, or add a barrier method. If you take lamotrigine with an estrogen pill, ask whether you need a dose adjustment to protect seizure control. These are short visits that pay off for years in safety and peace of mind.
Sources:
neurology.org, cdc.gov, stacks.cdc.gov
